HappeningToo topic
Cyclobenzaprine reports
Browse community reports connected to Cyclobenzaprine. These reports can show that other people are describing similar experiences, but they do not prove that Cyclobenzaprine caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
39 problems
Abdominal Discomfort while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and abdominal discomfort appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and abdominal pain upper appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and abdominal pain appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and acid reflux appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and alopecia appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and anxiety appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and back pain appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and constipation appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and cough appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and decreased appetite appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and diarrhea appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and dizziness appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and dry mouth appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and excessive sweating appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and fatigue appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and feeling abnormal appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and headache appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and hives appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and hypotension appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and insomnia appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and itching appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and malaise appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and migraine appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and muscle spasms appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and muscular weakness appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and myalgia appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and nausea appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Neck Pain while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and neck pain appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and pain appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and rash appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and shortness of breath appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and skin redness appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and sleepiness appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and tingling or pins and needles appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and tremor appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and vomiting appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and weakness appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and weight decreased appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Cyclobenzaprine
FDA FAERS contains adverse-event reports in which Cyclobenzaprine and weight increased appear together. This does not establish that Cyclobenzaprine caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →